Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Small Cap Fund | Axis Small Cap Fund | |
|---|---|---|
| Category | Small Cap | Small Cap |
| Plan | Regular | Regular |
| Fund house | Nippon India | Axis |
| NAV | ₹179.8094 | ₹116.0300 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 16.2 years | 13.0 years |
| Expense ratio | 1.4% | 1.7% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 58.30 | 73.40 |
Returns
| Nippon India Small Cap Fund | Axis Small Cap Fund | |
|---|---|---|
| 1 month | +1.66% | +3.98% |
| 3 months | −3.45% | −1.76% |
| 6 months | +4.70% | +9.40% |
| YTD | +8.10% | +10.75% |
| 1 year | +5.62% | +7.98% |
| 3 years (CAGR) | +11.93% | +12.36% |
| 5 years (CAGR) | +16.28% | +13.61% |
| 10 years (CAGR) | +20.19% | +18.45% |
| Since launch | +19.56% | +20.80% |
Risk
| Nippon India Small Cap Fund | Axis Small Cap Fund | |
|---|---|---|
| Volatility | 19.4% | 17.3% |
| Downside volatility | 12.6% | 11.4% |
| Sharpe | 0.28 | 0.34 |
| Sortino | 0.43 | 0.51 |
| Calmar | 0.49 | 0.62 |
| Return / risk | 0.62 | 0.71 |
| Deepest fall | −49.72% | −34.78% |
| Days to recover | 281 | 238 |
| Below its high | −3.74% | −2.08% |
Against benchmark
| Nippon India Small Cap Fund | Axis Small Cap Fund | |
|---|---|---|
| Alpha | +0.83% | +1.76% |
| Beta | 0.87 | 0.77 |
| R² | 96.1% | 94.8% |
| Up capture | 87.9% | 86.0% |
| Down capture | 81.3% | 75.7% |
| Tracking error | 4.7% | 6.3% |
| Information ratio | 0.01 | 0.06 |
| Treynor | 0.05 | 0.07 |
Consistency
| Nippon India Small Cap Fund | Axis Small Cap Fund | |
|---|---|---|
| Best 1-year | +151.62% | +98.68% |
| Middle 1-year | +13.83% | +14.82% |
| Worst 1-year | −36.19% | −16.01% |
| 1-year periods with a loss | 24.5% | 12.5% |
| Middle 3-year | +25.16% | +18.10% |
| Positive months | 55.6% | 63.9% |
| Best day | +3.66% | +3.31% |
| Worst day | −6.93% | −4.84% |
| Worst 5% day | −1.85% | −1.69% |
| Positive days | 58.0% | 54.4% |
| NAVs a year | 247 | 251 |
SIP of ₹10,000 a month
| Nippon India Small Cap Fund | Axis Small Cap Fund | |
|---|---|---|
| 5-year XIRR | +14.57% | +13.88% |
| 5-year value | ₹8,70,576 | ₹8,55,486 |
| 3-year XIRR | +6.96% | +9.65% |
| 1-year XIRR | +10.01% | +14.98% |
Holdings overlap i
| Nippon India Small Cap Fund | Axis Small Cap Fund | |
|---|---|---|
| Nippon India Small Cap Fund | — | 28% |
| Axis Small Cap Fund | 28% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India Small Cap Fund | Axis Small Cap Fund |
|---|---|---|
| Karur Vysya Bank Limited | 1.48% | 1.48% |
| Sai Life Sciences Limited | 1.33% | 1.97% |
| HDFC Bank Limited | 2.02% | 1.29% |
| Multi Commodity Exchange of India Limited | 1.16% | 1.10% |
| Avalon Technologies Limited | 1.03% | 1.42% |
| Craftsman Automation Limited | 0.80% | 1.38% |
| Kirloskar Oil Engines Limited | 0.79% | 1.06% |
| Union Bank of India | 1.00% | 0.78% |
| Gland Pharma Limited | 0.74% | 1.36% |
| TBO Tek Limited | 0.68% | 1.05% |
| PNB Housing Finance Limited | 0.65% | 1.45% |
| Navin Fluorine International Limited | 0.64% | 1.55% |
| Kalpataru Projects International Limited | 0.63% | 1.17% |
| Radico Khaitan Limited | 0.63% | 0.78% |
| Balrampur Chini Mills Limited | 0.85% | 0.59% |
| Delhivery Limited | 0.56% | 0.69% |
| Krishna Institute Of Medical Sciences Limited | 0.56% | 2.28% |
| Carborundum Universal Limited | 0.55% | 0.64% |
| Rategain Travel Technologies Limited | 0.55% | 0.76% |
| Fine Organic Industries Limited | 0.52% | 1.09% |
| Timken India Limited | 0.51% | 0.60% |
| Apar Industries Limited | 1.65% | 0.48% |
| Grindwell Norton Limited | 0.45% | 0.58% |
| Sansera Engineering Limited | 0.45% | 1.77% |
| Affle 3i Limited | 0.45% | 0.59% |
Sectors and company size
| Nippon India Small Cap Fund | Axis Small Cap Fund | |
|---|---|---|
| Large companies | 15.6% | 6.6% |
| Mid companies | 13.1% | 9.6% |
| Small companies | 65.2% | 73.7% |
| Top 10 holdings | 14.7% | 18.4% |
| Largest sector | Electrical Equipment 9% | Pharmaceuticals & Biotechnology 9% |